Mechanisms of Tumor Metastasis to the Bone: Challenges and Opportunities
Open Access
- 1 February 2003
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 18 (2) , 190-194
- https://doi.org/10.1359/jbmr.2003.18.2.190
Abstract
In human cancers, bone is a common site for metastasis. It is well known that metastasis is the cause of morbidity and mortality in patients with cancer. Both breast and prostate carcinomas have a propensity to metastasize to bone. In general, metastatic breast cancers result in osteolytic lesions. On the other hand, prostate cancer metastases are osteoblastic and result in osteosclerosis. Thus, bone formation and bone resorption are at the crux of the cancer metastasis problem. For example, in the prostate, there is a vicious cycle of metastasis to bone (Fig. 1). Metastases to bone causes excruciating bone pain, pathological fractures, and eventually death, and therefore is a serious challenge to both bone biologists and cancer cell biologists. The stromal‐epithelial interactions in breast and prostate are critical in initiation of carcinogenesis and the progression of the metastatic cascade to bone (Fig. 2). Over a hundred years ago, Stephen Paget enunciated the seed and soil hypothesis in which seeds of metastatic cancer cells of breast preferentially settle in the soil of bone matrix. Thus, the prostate/breast cancer bone interface and continuum has continuously presented challenges and opportunities and were discussed at a recent workshop.Keywords
This publication has 25 references indexed in Scilit:
- Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progressionProceedings of the National Academy of Sciences, 2001
- Biology of Osteoclast Activation in CancerJournal of Clinical Oncology, 2001
- Extending preclinical models of skeletal manifestations of malignancy to the clinical settingSeminars in Oncology, 2001
- Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cellsInternational Journal of Cancer, 2001
- The tumor microenvironment as a determinant of cancer cell survival: a possible mechanism for de novo drug resistanceCurrent Opinion in Oncology, 2000
- Actions of bisphosphonate on bone metastasis in animal models of breast carcinomaCancer, 2000
- Establishment of human prostate carcinoma skeletal metastasis modelsCancer, 2000
- Molecular Mechanisms of Tumor-Bone Interactions in Osteolytic MetastasesCritical Reviews™ in Eukaryotic Gene Expression, 2000
- Mechanisms of Tumor Metastasis to BoneCritical Reviews™ in Eukaryotic Gene Expression, 2000
- Factors regulating the growth of metastatic cancer in bone.Endocrine-Related Cancer, 1999